INSP
Inspire Medical Systems, Inc.
NYSE · Healthcare · Medical - Devices · US
$63.08
+1.51%Year over year
Reported trailing growth
- Revenue
- +4.3%
- EBITDA
- -4.7%
- EBIT
- +30.7%
- EPS
- +161.8%
- Free cash flow
- +37.7%
- Operating cash flow
- +33.7%
Forward estimates
Based on analyst estimates
- Revenue
- -3.8%
- EBITDA
- -19.9%
- EPS
- -72.7%
Three-year CAGR
- Revenue
- +30.8%
- EBITDA
- +22.7%
- EBIT
- +41.2%
- Net income
- +171.8%
- EPS
- +175.0%
- Free cash flow
- +216.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026